Literature DB >> 18193384

Invasive group B Streptococcal disease in non-pregnant adults : a review with emphasis on skin and soft-tissue infections.

P Sendi1, L Johansson, A Norrby-Teglund.   

Abstract

Streptococcus agalactiae, commonly referred as group B Streptococcus (GBS), is a major cause of neonatal sepsis and infections in pregnant women. However, the number of invasive infections in non-pregnant adults is growing. Elderly patients and those with chronic underlying conditions, such as diabetes mellitus or compromised immune defence, are at increased risk of invasion. The spectrum of clinical manifestations is broad and includes necrotizing fasciitis and toxic shock syndrome. Although, primary bacteremia and skin and soft-tissue infections are the most frequently reported diagnosis. This article reviews the epidemiology, pathogenesis and treatment of invasive GBS disease in non-pregnant adults, with an emphasis on skin and soft-tissue infections.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193384     DOI: 10.1007/s15010-007-7251-0

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  51 in total

1.  The homodimeric GBS1074 from Streptococcus agalactiae.

Authors:  Anshuman Shukla; Mark Pallen; Mark Anthony; Scott A White
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2010-10-27

2.  Structure of Streptococcus agalactiae tip pilin GBS104: a model for GBS pili assembly and host interactions.

Authors:  Vengadesan Krishnan; Prabhat Dwivedi; Brandon J Kim; Alexandra Samal; Kevin Macon; Xin Ma; Arunima Mishra; Kelly S Doran; Hung Ton-That; Sthanam V L Narayana
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-05-15

3.  Changing Epidemiology of Group B Streptococcus Susceptibility to Fluoroquinolones and Aminoglycosides in France.

Authors:  Constantin Hays; Mathilde Louis; Céline Plainvert; Nicolas Dmytruk; Gérald Touak; Patrick Trieu-Cuot; Claire Poyart; Asmaa Tazi
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

4.  Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults.

Authors:  Charlotte A Huber; Francis McOdimba; Valentin Pflueger; Claudia A Daubenberger; Gunturu Revathi
Journal:  J Clin Microbiol       Date:  2011-08-24       Impact factor: 5.948

5.  Skin and soft tissue infections in hospitalised patients with diabetes: culture isolates and risk factors associated with mortality, length of stay and cost.

Authors:  B A Lipsky; Y P Tabak; R S Johannes; L Vo; L Hyde; J A Weigelt
Journal:  Diabetologia       Date:  2010-02-10       Impact factor: 10.122

Review 6.  Intrinsic Maturational Neonatal Immune Deficiencies and Susceptibility to Group B Streptococcus Infection.

Authors:  Michelle L Korir; Shannon D Manning; H Dele Davies
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

7.  Molecular characterization and prophage DNA contents of Streptococcus agalactiae strains isolated from adult skin and osteoarticular infections.

Authors:  Mazen Salloum; Nathalie van der Mee-Marquet; Anne-Sophie Domelier; Laurence Arnault; Roland Quentin
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

8.  Prevalence and molecular diversity of invasive Streptococcus dysgalactiae and Streptococcus pyogenes in a German tertiary care medical centre.

Authors:  S Rößler; R Berner; E Jacobs; N Toepfner
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-03       Impact factor: 3.267

9.  Novel structure of the N-terminal helical domain of BibA, a group B streptococcus immunogenic bacterial adhesin.

Authors:  Kartik Manne; Debasish Chattopadhyay; Vaibhav Agarwal; Anna M Blom; Baldeep Khare; Srinivas Chakravarthy; Chungyu Chang; Hung Ton-That; Sthanam V L Narayana
Journal:  Acta Crystallogr D Struct Biol       Date:  2020-07-27       Impact factor: 7.652

10.  Streptococcus agalactiae infection in cancer patients: a five-year study.

Authors:  B A S Pimentel; C A S Martins; J C Mendonça; P S D Miranda; G F Sanches; A L Mattos-Guaraldi; P E Nagao
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-03-18       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.